Role of coronary angiogram before transcatheter aortic valve implantation

doi:10.4330/wjc.v13.i8.361

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3436)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

188

WORD

HTML

2279

Figures (1-3)

155

Tables (1-3)

168

Sum=2862

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

265

Download

309

Sum=574

Aug 26, 2021 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Cardiol. Aug 26, 2021; 13(8): 361-371
Published online Aug 26, 2021. doi: 10.4330/wjc.v13.i8.361

Table 3 Clinical endpoints following transcatheter aortic valve implantation procedure

	Whole group (n = 348)	No coronary angiogram group (n = 194)	Coronary angiogram group (n = 154)	P value
Primary endpoint, n (%)	78 (22.4)	44 (22.6)	33 (22.2)	NS
Death, n (%)	63 (18.1)	37 (19.0)	26 (17.0)	NS
Myocardial infarction, n (%)	8 (2.3)	2 (1.0)	6 (3.9)	NS
Readmission with heart failure, n (%)	14 (4)	12 (6.2)	2 (1.3)	< 0.05
Coronary angiogram post valve intervention, n (%)	10 (2.9)	1 (0.5)	9 (5.8)	< 0.01
Death & myocardial infarction, n (%)	69 (19.8)	38 (19.5)	31 (20.3)	NS
Death & readmission with heart failure, n (%)	70 (20.1)	43 (22.1)	27 (17.6)	NS
Myocardial infarction & readmission with heart failure, n (%)	21 (6)	13 (6.7)	8 (5.2)	NS

Primary endpoint was defined as a composite of death, myocardial infarction, revascularisation, and readmission with heart failure. NS: No significant difference.

Citation: Beska B, Manoharan D, Mohammed A, Das R, Edwards R, Zaman A, Alkhalil M. Role of coronary angiogram before transcatheter aortic valve implantation. World J Cardiol 2021; 13(8): 361-371
URL: https://www.wjgnet.com/1949-8462/full/v13/i8/361.htm
DOI: https://dx.doi.org/10.4330/wjc.v13.i8.361